Eric Rasmussen is Adient’s vice president, strategy, leading global strategy development and planning for the company.
Previously, Rasmussen was chief financial officer for Meridian Bioscience. Prior to that, Rasmussen served in strategy, corporate development, and finance leadership roles at Lear Corporation starting in 2002. He was also previously an investment banker and research analyst with Merrill Lynch and Schroders.
Rasmussen earned an MBA from Duke University’s Fuqua School of Business and a bachelor’s degree in management from Kettering University.